Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.12 (Beat by $0.03) |
EPS GAAP Actual | $0.12 (Beat by $0.03) |
Revenue Actual | $0.3026B |
Revenue Surprise | Beat by $302.6M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.275 | 50.18 | 1.22092 | 1.39716 | 1 |
Dec 2028 | 1.05 | 60.93 | 0.99568 | 1.08681 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 0.3026B | 8.39% | 302.6M |
FQ4 2024 (Dec 2024) | 0.0255 | 0.0255 | 0.2831B | 3% | 283.1M |
FQ3 2024 (Sep 2024) | 0.021 | 0.021 | 0.2759B | 100% | 275.9M |
FQ2 2024 (Jun 2024) | 0.052 | 0.052 | 0.3001B | 14.4% | 300.1M |
FQ1 2024 (Mar 2024) | 0.0093 | 0.0093 | 0.2772B | 16.38% | 277.2M |
FQ4 2023 (Oct 2023) | -0.0123 | -0.0123 | 0.2746B | 9.21% | 274.6M |
FQ2 2023 (Jun 2023) | -0.0209 | -0.0209 | 0.2569B | 12.73% | 256.9M |
FQ1 2023 (Mar 2023) | -0.0453 | -0.0453 | 0.2318B | 100% | 231.8M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.23 | -- | 0.23 | 0.23 | 5 |
FQ3 2027 (Sep 2027) | 0.21 | -- | 0.21 | 0.21 | 5 |
FQ2 2027 (Jun 2027) | 0.19 | -- | 0.19 | 0.19 | 5 |
FQ1 2027 (Mar 2027) | 0.18 | -- | 0.18 | 0.18 | 5 |
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 3 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 5 |
FQ2 2026 (Jun 2026) | 0.1675 | -- | 0.16167 | 0.17544 | 2 |
FQ1 2026 (Mar 2026) | 0.16 | 81.25 | 0.15244 | 0.16765 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.43B | -- | 0.43B | 0.43B | 6 |
FQ3 2027 (Sep 2027) | 0.41B | -- | 0.41B | 0.41B | 6 |
FQ2 2027 (Jun 2027) | 0.4B | -- | 0.4B | 0.4B | 6 |
FQ1 2027 (Mar 2027) | 0.39B | -- | 0.39B | 0.39B | 6 |
FQ4 2026 (Oct 2026) | 0.36B | -- | 0.34B | 0.36B | 4 |
FQ3 2026 (Jul 2026) | 0.34B | -- | 0.33B | 0.35B | 6 |
FQ2 2026 (Jun 2026) | 0.38B | -- | 0.37B | 0.39B | 3 |
FQ1 2026 (Mar 2026) | 0.33B | 8.66 | 0.32B | 0.34B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.03 | 0.03 | 100% | |
FQ4 2024 (Dec 2024) | 0.0255 | 0.0255 | 100% | |
FQ3 2024 (Sep 2024) | 0.021 | 0.021 | 100% | |
FQ2 2024 (Jun 2024) | 0.052 | 0.052 | 100% | |
FQ1 2024 (Mar 2024) | 0.0093 | 0.0093 | 100% | |
FQ4 2023 (Oct 2023) | -0.0123 | -0.0123 | 100% | |
FQ2 2023 (Jun 2023) | -0.0209 | -0.0209 | 100% | |
FQ1 2023 (Mar 2023) | -0.0453 | -0.0453 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.3B | $302.6M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.28B | $283.1M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.28B | $275.9M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.3B | $300.1M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.28B | $277.2M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.27B | $274.6M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.26B | $256.9M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.23B | $231.8M | 100% |